Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

Celgene calls it quits on expensive Crohn's drug

$
0
0
The big biotech is discontinuing development of a potential blockbuster putting pressure on its pipeline product ozanimod to outperform.

Viewing all articles
Browse latest Browse all 2985

Trending Articles